# Kallyope

**Canonical:** https://apis.io/providers/kallyope/  
**Website:** https://kallyope.com/  
**APIs profiled:** 1

Kallyope, Inc. is a New York City clinical-stage biotechnology company, founded in 2015 by Columbia University scientists Charles Zuker, Tom Maniatis and Richard Axel, that translates the biology of the gut-brain axis into medicines. It launched with a $44M Series A and has since raised a $66M Series B, a $112M Series C and a $236M Series D co-led by Mubadala Investment Company and The Column Group, with backers including Bill Gates, Lux Capital, Polaris Partners, Casdin Capital and Alexandria Real Estate Equities. Its proprietary Klarity platform integrates single-cell sequencing, pathway circuit mapping, optogenetics and chemogenetics, proprietary human genetics, mouse and human organoid systems, and small-molecule and peptide chemistry to map the neural circuits underlying migraine and metabolism; lead candidate elismetrep, a TRPM8 blocker, is in Phase 3 development for acute migraine. Kallyope publishes no developer portal, API reference, SDKs, CLI, status page or public GitHub organization, and no OpenAPI, AsyncAPI, GraphQL, MCP or A2A agent-card surface was found on any host. Enrichment probing did find one real, anonymous, read-only REST surface: kallyope.com runs WordPress and exposes the WordPress REST API publicly at https://kallyope.com/wp-json, carrying the company news feed, site pages, media library and a first-party "document" content type of scientific posters, presentations and publications classified by the custom program, event, content-type and document-type taxonomies.

## Kin Score — 13.4 / 100 (emerging)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 14.1).

| Facet | Score |
|---|---|
| Discoverability | 68.5 |
| Contract Quality | 15.3 |
| Governance | 16.7 |
| Contract Governance | 16.7 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 13.8 (matched via tags).

## Agent readiness — 15.0 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| Reversibility Documented | na |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | na |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | na |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## APIs (1)

- **Kallyope Content REST API** — Anonymous, read-only REST surface behind kallyope.com. Kallyope runs WordPress and exposes the WordPress REST API publicly at https://kallyope.com/wp-json with 326 registered ro...

## MCP servers (1)

- **Kallyope MCP Server**

## Security (2)

- **Kallyope Authentication** — none/http · 3 schemes
- **Kallyope Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Life Sciences, Pharmaceuticals, Drug Discovery, Neuroscience, Gut-Brain Axis, Migraine, Metabolic Disease, Clinical Trials, Content

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/kallyope/). Scores are computed from the provider's own public artifacts under a published rubric.